Abstract
With the development and approval of cutting-edge immune-based approaches for cancer treatment in the latest years, the global immune-oncological (IO) pipelines have dramatically increased. To overcome the challenges of growing...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
